Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome
Journal of Neurology, Neurosurgery & Psychiatry
Fecha de publicación: Marzo de 2021
Autores: Yuta Kojima, Akiyuki Uzawa, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Hiroyuki Akamine, Naoki Kawaguchi, Keiichi Himuro, Yu-ichi Noto, Toshiki Mizuno, Satoshi Kuwabara
DOI: http://dx.doi.org/10.1136/jnnp-2020-325511
Objective: To investigate the association between changes in anti-acetylcholine receptor antibody (AChR Ab) levels induced by immunosuppressive treatment and myasthenia gravis (MG) prognosis at 1-year post-treatment in patients with MG.
